Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LEODOLTER S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Umek, WH; Obermair, A; Stutterecker, D; Hausler, G; Leodolter, S; Hanzal, E
      Three-dimensional ultrasound of the female urethra: comparing transvaginaland transrectal scanning

      ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    2. Bodner-Adler, B; Bodner, K; Obermair, A; Czerwenka, K; Petru, E; Leodolter, S; Mayerhofer, K
      Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study

      ANTICANCER RESEARCH
    3. Muller-Klingspor, V; Hefler, L; Obermair, A; Kaider, A; Breitenecker, G; Leodolter, S; Kohlberger, P
      Prognostic value of beta 1-integrin (=CD29) in serous adenocarcinomas of the ovary

      ANTICANCER RESEARCH
    4. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Schindl, M; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients

      ANTICANCER RESEARCH
    5. Bodner-Adler, B; Hefler, L; Bodner, K; Leodolter, S; Frischmuth, K; Kainz, C; Mayerhofer, K
      Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN)

      ANTICANCER RESEARCH
    6. Pribill, I; Speiser, P; Leary, J; Leodolter, S; Hacker, NF; Friedlander, ML; Birnbaum, D; Zeillinger, R; Krainer, M
      High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma

      CANCER GENETICS AND CYTOGENETICS
    7. Obermair, A; Schmid, BC; Stimpfl, M; Fasching, B; Preyer, O; Leodolter, S; Crandon, AJ; Zeillinger, R
      Novel MUC1 splice variants are expressed in cervical carcinoma

      GYNECOLOGIC ONCOLOGY
    8. Bodner, K; Bodner-Adler, B; Obermair, A; Windbichler, G; Petru, E; Mayerhofer, S; Czerwenka, K; Leodolter, S; Kainz, C; Mayerhofer, K
      Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients

      GYNECOLOGIC ONCOLOGY
    9. Bodner, K; Bodner-Adler, B; Wagenbichler, P; Kaider, A; Leodolter, S; Husslein, P; Mayerhofer, K
      Perineal lacerations during spontaneous vaginal delivery

      WIENER KLINISCHE WOCHENSCHRIFT
    10. Bodner-Adler, B; Bodner, K; Kaider, A; Wagenbichler, P; Leodolter, S; Husslein, P; Mayerhofer, K
      Risk factors for third-degree perineal tears in vaginal delivery, with an analysis of episiotomy types

      JOURNAL OF REPRODUCTIVE MEDICINE
    11. Tong, D; Fabjani, G; Heinze, G; Obermair, A; Leodolter, S; Zeillinger, R
      Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients

      INTERNATIONAL JOURNAL OF CANCER
    12. Mayerhofer, K; Bodner, K; Bodner-Adler, B; Schindl, M; Kaider, A; Hefler, L; Zeillinger, R; Leodolter, S; Joura, EA; Kainz, C
      Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy

      CANCER
    13. Hefler, L; Tempfer, C; Frischmuth, K; Maenner, G; Concin, N; Sliutz, G; Reinthaller, A; Leodolter, S; Kainz, C
      Serum concentrations of tissue polypeptide antigen in patients with vulvarintraepithelial neoplasia and vulvar cancer

      TUMOR BIOLOGY
    14. Kucera, E; Schindl, M; Klem, I; Sam, C; Hanzal, E; Kolbl, H; Leodolter, S; Sliutz, G
      Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    15. Kucera, E; Kainz, C; Reinthaller, A; Sliutz, G; Leodolter, S; Kucera, H; Breitenecker, G
      Accuracy of intraoperative frozen-section diagnosis in stage I endometrialadenocarcinoma

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    16. Concin, N; Zeillinger, C; Stimpfel, M; Schiebel, I; Tong, D; Wolff, U; Reiner, A; Leodolter, S; Zeillinger, R
      p53-dependent radioresistance in ovarian carcinoma cell lines

      CANCER LETTERS
    17. Mayerhofer, K; Bodner-Alder, B; Bodner, K; Leodolter, S; Kainz, C
      Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: Efficacy and adverse effects with special consideration of peripheral neurotoxicity

      ANTICANCER RESEARCH
    18. Mayerhofer, K; Bodner-Adler, B; Bodner, K; Saletu, B; Schindl, M; Kaider, A; Hefler, L; Leodolter, S; Kainz, C
      A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: A prospective study in patients with ovarian cancer

      ANTICANCER RESEARCH
    19. Mayerhofer, K; Bodner, K; Aktas, C; Schindl, M; Kaider, A; Leodolter, S; Joura, EA; Kainz, C
      Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers

      ANTICANCER RESEARCH
    20. Mayerhofer, K; Hefler, L; Zeisler, H; Tempfer, C; Bodner, K; Stockler-Ipsiroglu, S; Muhl, A; Kaider, A; Schatten, C; Leodolter, S; Husslein, P; Kainz, C
      Serum homocyst(e)ine levels in women with preeclampsia

      WIENER KLINISCHE WOCHENSCHRIFT
    21. Mayerhofer, K; Bodner, K; Saletu, B; Bodner-Adler, B; Anderer, P; Hefler, L; Kaider, A; Leodolter, S; Kainz, C
      Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients

      WIENER KLINISCHE WOCHENSCHRIFT
    22. Kucera, E; Tong, D; Reinthaller, A; Leodolter, S; Zeillinger, R; Sliutz, G
      p53 polymorphism at codon 72 - does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?

      WIENER KLINISCHE WOCHENSCHRIFT
    23. Kucera, E; Leodolter, S
      Methotrexate - A non-surgical treatment alternative in tubal pregnancy

      WIENER KLINISCHE WOCHENSCHRIFT
    24. Kucera, E; Helbich, TH; Klem, I; Schurz, B; Sliutz, G; Leodolter, S; Joura, EA
      Systemic methotrexate treatment of interstitial pregnancy - Magnetic resonance imaging (MRI) as a valuable tool for monitoring treatment

      WIENER KLINISCHE WOCHENSCHRIFT
    25. Joura, EA; Losch, A; Haider-Angeler, MG; Breitenecker, G; Leodolter, S
      Trends in vulvar neoplasia - Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women

      JOURNAL OF REPRODUCTIVE MEDICINE
    26. Tong, D; Kucera, E; Schuster, E; Schmutzler, RK; Swoboda, H; Reinthaller, A; Leodolter, S; Zeillinger, R
      Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors

      INTERNATIONAL JOURNAL OF CANCER
    27. Tong, D; Kucera, E; Stimpfl, M; Kolbl, H; Leodolter, S; Zeillinger, R
      Detection of p53 polymorphism at codon 72 by PCR and allele-specific oligonucleotide hybridization on microtiter plates

      CLINICAL CHEMISTRY
    28. Hefler, LA; Rosen, AG; Graf, AH; Lahousen, M; Klein, M; Leodolter, S; Reinthaller, A; Kainz, C; Tempfer, CB
      The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma - A multicenter study

      CANCER
    29. Tong, D; Schneeberger, C; Czerwenka, K; Schmutzler, RK; Speiser, P; Kucera, E; Concin, N; Kubista, E; Leodolter, S; Zeillinger, R
      Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer

      CLINICAL CANCER RESEARCH
    30. Hefler, L; Tempfer, C; Obermair, A; Frischmuth, K; Sliutz, G; Reinthaller, A; Leodolter, S; Kainz, C
      Serum concentrations of vascular endothelial growth factor in vulvar cancer

      CLINICAL CANCER RESEARCH
    31. Speiser, P; Kridelka, F; Tempfer, C; Edwards, L; Leodolter, S; Kainz, C; Hacker, NF
      CD44v6 expression is an independent prognostic factor in node-negative FIGO stage IB cervical carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    32. Stimpfl, M; Schmid, BC; Obermair, A; Tong, D; Schiebel, I; Gitsch, G; Leodolter, S; Zeillinger, R
      Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral blood

      ONCOLOGY RESEARCH
    33. Stimpfl, M; Schmid, BC; Schiebel, I; Tong, D; Leodolter, S; Obermair, A; Zeillinger, R
      Expression of mucins and cytokeratins in ovarian cancer cell lines

      CANCER LETTERS
    34. Obermair, A; Wasicky, R; Kaider, A; Preyer, O; Losch, A; Leodolter, S; Kolbl, H
      Prognostic significance of tumor angiogenesis in epithelial ovarian cancer

      CANCER LETTERS
    35. Mayerhofer, K; Hefler, L; Schindl, M; Concin, N; Frischmuth, K; Leodolter, S; Zeillinger, R; Reinthaller, A; Kainz, C
      p53 antibody response in patients with vulvar cancer

      ANTICANCER RESEARCH
    36. Tong, D; Czerwenka, K; Sedlak, J; Schneeberger, C; Schiebel, I; Concin, N; Leodolter, S; Zeillinger, R
      Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines

      BREAST CANCER RESEARCH AND TREATMENT
    37. Peters-Engl, C; Frank, W; Danmayr, E; Friedl, HP; Leodolter, S; Medl, M
      Association between endometrial cancer and tamoxifen treatment of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    38. Peters-Engl, C; Frank, W; Leodolter, S; Medl, M
      Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of survival

      BREAST CANCER RESEARCH AND TREATMENT
    39. Mayerhofer, K; Obermair, A; Windbichler, G; Petru, E; Kaider, A; Hefler, L; Czerwenka, K; Leodolter, S; Kainz, C
      Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases

      GYNECOLOGIC ONCOLOGY
    40. Obermair, A; Preyer, O; Leodolter, S
      Impact of angiogenesis in gynecology and obstetrics

      WIENER KLINISCHE WOCHENSCHRIFT
    41. Hefler, L; Obermair, A; Tempfer, C; van Houte, M; Maenner, G; Reinthaller, A; Leodolter, S; Kainz, C
      Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer

      INTERNATIONAL JOURNAL OF CANCER
    42. Hefler, L; Frischmuth, K; Heinze, G; Sliutz, G; Leodolter, S; Reinthaller, A; Kainz, C; Tempfer, C
      Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer

      INTERNATIONAL JOURNAL OF CANCER
    43. Obermair, A; Obruca, A; Pohl, M; Kaider, A; Vales, A; Leodolter, S; Wojta, J; Feichtinger, W
      Vascular endothelial growth factor and its receptors in male fertility

      FERTILITY AND STERILITY
    44. Tong, D; Stimpfl, M; Reinthaller, A; Vavra, N; Mullauer-Ertl, S; Leodolter, S; Zeillinger, R
      BRCAI gene mutations in sporadic ovarian carcinomas: Detection by PCR and reverse allele-specific oligonucleotide hybridization

      CLINICAL CHEMISTRY
    45. Hefler, L; Tempfer, C; Heinze, G; Mayerhofer, K; Breitenecker, G; Leodolter, S; Reinthaller, A; Kainz, C
      Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients

      BRITISH JOURNAL OF CANCER
    46. Hefler, L; Kainz, C; Zeisler, H; Heinze, G; Schatten, C; Husslein, P; Leodolter, S; Tempfer, C
      Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    47. OBERMAIR A; JIRECEK S; LEODOLTER S
      EPIDEMIOLOGIC CONSIDERATIONS ON THE SIGNIFICANCE OF HORMONES IN CARCINOGENESIS

      Gynakologisch-geburtshilfliche Rundschau
    48. WINTER R; CONCIN H; FUITH L; LAHOUSEN M; LEODOLTER S; SALZER H; STUMMVOLL W
      GUIDELINES FOR SURGICAL-TREATMENT OF CERV ICAL-CANCER ESTABLISHED BY THE STANDARDS COMMITTEE OF THE AUSTRIAN-SOCIETY-FOR-OBSTETRICS-AND-GYNECOLOGY

      Gynakologisch-geburtshilfliche Rundschau
    49. OBERMAIR A; WANNER C; BILGI S; SPEISER P; KAIDER A; REINTHALLER A; LEODOLTER S; GITSCH G
      PROGNOSTIC IMPACT OF MICROVESSEL DENSITY IN STAGE IB CARCINOMA OF THEUTERINE CERVIX

      Annals of oncology
    50. OBERMAIR A; WANNER C; BILGI S; SPEISER P; REISENBERGER K; KAIDER A; KAINZ C; LEODOLTER S; BREITENECKER G; GITSCH G
      THE INFLUENCE OF VASCULAR SPACE INVOLVEMENT ON THE PROGNOSIS OF PATIENTS WITH STAGE IB CERVICAL-CARCINOMA - CORRELATION OF RESULTS FROM HEMATOXYLIN AND EOSIN STAINING WITH RESULTS FROM IMMUNOSTAINING FOR FACTOR VIII-RELATED ANTIGEN

      Cancer
    51. KOHLBERGER PD; KIRNBAUER R; BANCHER D; GITSCH G; REINTHALLER A; LEODOLTER S; TSCHACHLER E; KAINZ C; BREITENECKER G
      ABSENCE OF P53 PROTEIN OVEREXPRESSION IN PRECANCEROUS LESIONS OF THE VULVA

      Cancer
    52. Obermair, A; Tempfer, C; Hefler, L; Preyer, O; Kaider, A; Zeillinger, R; Leodolter, S; Kainz, C
      Concentration of vascular endothelial growth factor (VEGF) in the serum ofpatients with suspected ovarian cancer

      BRITISH JOURNAL OF CANCER
    53. OBERMAIR A; WANNER C; BILGI S; SPEISER P; KAIDER A; REINTHALLER A; LEODOLTER S; GITSCH G
      TUMOR ANGIOGENESIS IN STAGE IB CERVICAL-CANCER - CORRELATION OF MICROVESSEL DENSITY WITH SURVIVAL

      American journal of obstetrics and gynecology
    54. MEDL M; OGRIS E; PETERSENGL C; MIERAU M; BUXBAUM P; LEODOLTER S
      SERUM LEVELS OF THE TUMOR-ASSOCIATED TRYPSIN-INHIBITOR IN PATIENTS WITH ENDOMETRIOSIS

      British journal of obstetrics and gynaecology
    55. BANCHERTODESCA D; OBERMAIR A; BILGI S; KOHLBERGER P; KAINZ C; BREITENECKER G; LEODOLTER S; GITSCH G
      ANGIOGENESIS IN VULVAR INTRAEPITHELIAL NEOPLASIA

      Gynecologic oncology
    56. OBERMAIR A; KUCERA E; MAYERHOFER K; SPEISER P; SEIFERT M; CZERWENKA K; KAIDER A; LEODOLTER S; KAINZ C; ZEILLINGER R
      VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IN HUMAN BREAST-CANCER - CORRELATION WITH DISEASE-FREE SURVIVAL

      International journal of cancer
    57. ZEILLINGER R; TONG DCC; VAVRA N; LEODOLTER S
      SIMULTANEOUS DETECTION OF FREQUENT BRCA1 MUTATIONS BY REVERSE HYBRIDIZATION ON MEMBRANE STRIPS

      Clinical chemistry
    58. TONG D; SCHNEEBERGER C; LEODOLTER S; ZEILLINGER R
      QUANTITATIVE-DETERMINATION OF GENE-EXPRESSION BY COMPETITIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IN DEGRADED RNA SAMPLES

      Analytical biochemistry
    59. OBERMAIR A; BANCHERTODESCA D; BILGI S; KAIDER A; KOHLBERGER P; MULLAUERERTL S; LEODOLTER S; GITSCH G
      CORRELATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION AND MICROVESSEL DENSITY IN CERVICAL INTRAEPITHELIAL NEOPLASIA

      Journal of the National Cancer Institute
    60. PETERSENGL C; MEDL M; DANMAYR E; MIRAU M; ALTH G; LEODOLTER S
      ENDOMETRIAL CANCER AFTER TAMOXIFEN TREATMENT - A DESCRIPTIVE STUDY OF25 BREAST-CANCER PATIENTS WHO SUBSEQUENTLY DEVELOPED ENDOMETRIAL CANCER

      Anticancer research
    61. OBERMAIR A; KOHLBERGER P; BANCHERTODESCA D; TEMPFER C; SLIUTZ G; LEODOLTER S; REINTHALLER A; KAINZ C; BREITENECKER G; GITSCH G
      INFLUENCE OF MICROVESSEL DENSITY AND VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION ON PROGNOSIS IN VULVAR CANCER

      Gynecologic oncology
    62. LEODOLTER S
      TRANSVAGINAL HYSTERECTOMY IN AUSTRIA - PA ST - PRESENT - FUTURE

      Gynakologisch-geburtshilfliche Rundschau
    63. PETERSENGL C; MEDL M; OGRIS E; LEODOLTER S
      TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) AND CANCER-ANTIGEN-125 (CA125) IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER

      Anticancer research
    64. MEDL M; MAYERHOFER K; PETERSENGL C; MAHRHOFER P; HUBER S; BUXBAUM P; SEVELDA P; LEODOLTER S
      THE APPLICATION OF FIBRIN GLUE AFTER AXILLARY LYMPHADENECTOMY IN THE SURGICAL-TREATMENT OF HUMAN BREAST-CANCER

      Anticancer research
    65. MEDL M; KULENKAMPFF KJ; STISKAL M; PETERSENGL C; LEODOLTER S; CZEMBIREK H
      MAGNETIC-RESONANCE-IMAGING IN THE PREOPERATIVE EVALUATION OF SUSPECTED OVARIAN MASSES

      Anticancer research
    66. MEDL M; SEVELDA P; CZERWENKA K; DOBIANER K; HANAK H; HRUZA C; KLEIN M; LEODOLTER S; MULLAUERERTL S; ROSEN A; SALZER H; VAVRA N; SPONA J
      DNA AMPLIFICATION OF HER-2 NEU AND INT-2 ONCOGENES IN EPITHELIAL OVARIAN-CANCER/

      Gynecologic oncology
    67. MEDL M; OGRIS E; PETERSENGL C; LEODOLTER S
      TATI (TUMOR-ASSOCIATED TRYPSIN-INHIBITOR) AS A MARKER OF OVARIAN-CANCER

      British Journal of Cancer
    68. PETERSENGL C; MEDL M; LEODOLTER S
      THE USE OF COLOR-CODED AND SPECTRAL DOPPLER ULTRASOUND IN THE DIFFERENTIATION OF BENIGN AND MALIGNANT BREAST-LESIONS

      British Journal of Cancer
    69. MEDL M; PETERSENGL C; LEODOLTER S
      THE USE OF COLOR-CODED DOPPLER SONOGRAPHY IN THE DIAGNOSIS OF BREAST-CANCER

      Anticancer research
    70. AUINGER M; DUDCZAK R; FASCHING W; LEODOLTER S; FEINBOCK C; IRSIGLER K
      DIAGNOSIS OF AN INSULINOMA DURING PREGNAN CY - A RARE CAUSE OF HYPOGLYCEMIA

      Wiener Klinische Wochenschrift
    71. HRUZA C; DOBIANER K; BECK A; CZERWENKA K; HANAK H; KLEIN M; LEODOLTER S; MEDL M; MULLAUERERTL S; PREISER J; ROSEN A; SALZER H; SEVELDA P; SPONA J
      HER-2 AND INT-2 AMPLIFICATION ESTIMATED BY QUANTITATIVE PCR IN PARAFFIN-EMBEDDED OVARIAN-CANCER TISSUE SAMPLES

      European journal of cancer
    72. MEDL M; PETERSENGEL C; FUCHS G; LEODOLTER S
      TRIPTORELIN (D-TRP-6-LHRH) IN COMBINATION WITH CARBOPLATIN-CONTAININGPOLYCHEMOTHERARY FOR ADVANCED OVARIAN-CANCER - A PILOT-STUDY

      Anticancer research
    73. THIEBAUD D; JANISCH S; KOELBL H; HANZAL E; JACQUET AF; LEODOLTER S; BURCKHARDT P; PECHERSTORFER M
      DIRECT EVIDENCE OF A PARATHYROID RELATED PROTEIN GRADIENT BETWEEN THEMOTHER AND THE NEWBORN IN HUMANS

      Bone and mineral
    74. ROSEN A; SEVELDA P; KLEIN M; DOBIANER K; HRUZA C; CZERWENKA K; HANAK H; VAVRA N; SALZER H; LEODOLTER S; MEDL M; SPONA J
      1ST EXPERIENCE WITH FGF-3 (INT-2) AMPLIFICATION IN WOMEN WITH EPITHELIAL OVARIAN-CANCER

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 13:33:50